speb/financial-data huggingface dataset:
CNS cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 14335000.00
CNS cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 39362000.00
CNS cash_flow (annual, 2025-12-31) — Net Other Financing Charges: 228216000.00
CNS cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 40715000.00
CNS balance_sheet (annual, 2025-12-31) — Net PPE: 162410000.00
CNS balance_sheet (quarterly, 2025-12-31) — Net PPE: 162410000.00
CNS cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -5979000.00
CNS cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -282000.00
CNS balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 541913000.00
CNS balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 541913000.00
CNS income_statement (annual, 2025-12-31) — Normalized EBITDA: 206574000.00
CNS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 51824000.00
CNS income_statement (annual, 2025-12-31) — Normalized Income: 149484860.00
CNS income_statement (quarterly, 2025-12-31) — Normalized Income: 37230660.45
CNS cash_flow (annual, 2025-12-31) — Operating Cash Flow: -120444000.00
CNS cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 1058000.00
CNS cash_flow (annual, 2025-12-31) — Operating Gains Losses: -7593000.00
CNS cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 2329000.00
CNS income_statement (annual, 2025-12-31) — Operating Income: 199745000.00
CNS income_statement (quarterly, 2025-12-31) — Operating Income: 45527000.00
CNS income_statement (annual, 2025-12-31) — Operating Revenue: 576181000.00
CNS income_statement (quarterly, 2025-12-31) — Operating Revenue: 148582000.00
CNS balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 51032114.00
CNS balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 51032114.00
CNS balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -4657000.00
CNS balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -4657000.00
CNS income_statement (annual, 2025-12-31) — Other Gand A: 71234000.00
CNS income_statement (quarterly, 2025-12-31) — Other Gand A: 19212000.00
CNS income_statement (annual, 2025-12-31) — Other Income Expense: 4885000.00
CNS income_statement (quarterly, 2025-12-31) — Other Income Expense: -3239000.00
CNS balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 1250000.00
CNS balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 1250000.00
CNS cash_flow (annual, 2025-12-31) — Other Non Cash Items: 5254000.00
CNS cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 1307000.00
CNS balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 30667000.00
CNS balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 30667000.00
CNS balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 13314000.00
CNS balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 13314000.00
CNS balance_sheet (annual, 2025-12-31) — Other Payable: 319000.00
CNS balance_sheet (quarterly, 2025-12-31) — Other Payable: 319000.00
CNS balance_sheet (annual, 2025-12-31) — Other Properties: 110086000.00
CNS balance_sheet (quarterly, 2025-12-31) — Other Properties: 110086000.00
CNS balance_sheet (annual, 2025-12-31) — Other Receivables: 1865000.00
CNS balance_sheet (quarterly, 2025-12-31) — Other Receivables: 1865000.00
CNS balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 165443000.00
CNS balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 165443000.00
CNS balance_sheet (annual, 2025-12-31) — Payables: 10592000.00
CNS balance_sheet (quarterly, 2025-12-31) — Payables: 10592000.00
CNS balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 10592000.00
CNS balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 10592000.00
CNS income_statement (annual, 2025-12-31) — Pretax Income: 204630000.00
CNS income_statement (quarterly, 2025-12-31) — Pretax Income: 42288000.00
CNS cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 961000.00
CNS cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 182000.00
CNS balance_sheet (annual, 2025-12-31) — Properties: 0.00
CNS balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
CNS cash_flow (annual, 2025-12-31) — Purchase Of Investment: -383416000.00
CNS cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -77818000.00
CNS cash_flow (annual, 2025-12-31) — Purchase Of PPE: -5979000.00
CNS cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -282000.00
CNS balance_sheet (annual, 2025-12-31) — Receivables: 81640000.00
CNS balance_sheet (quarterly, 2025-12-31) — Receivables: 81640000.00
CNS income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 295432000.00
CNS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 81223000.00
CNS income_statement (annual, 2025-12-31) — Reconciled Depreciation: 11714000.00
CNS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 3058000.00
CNS cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -28416000.00
CNS cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -1560000.00
CNS balance_sheet (annual, 2025-12-31) — Retained Earnings: -105806000.00
CNS balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -105806000.00
CNS cash_flow (annual, 2025-12-31) — Sale Of Investment: 397751000.00
CNS cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 117180000.00
CNS income_statement (annual, 2025-12-31) — Selling General And Administration: 71234000.00
CNS income_statement (quarterly, 2025-12-31) — Selling General And Administration: 19212000.00
CNS balance_sheet (annual, 2025-12-31) — Share Issued: 58275965.00
CNS balance_sheet (quarterly, 2025-12-31) — Share Issued: 58275965.00
CNS cash_flow (annual, 2025-12-31) — Stock Based Compensation: 45962000.00
CNS cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 10085000.00
CNS balance_sheet (annual, 2025-12-31) — Stockholders Equity: 561953000.00
CNS balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 561953000.00
CNS balance_sheet (annual, 2025-12-31) — Tangible Book Value: 541913000.00
CNS balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 541913000.00
CNS income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 1152860.00
CNS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -887339.55
CNS income_statement (annual, 2025-12-31) — Tax Provision: 47232000.00
CNS income_statement (quarterly, 2025-12-31) — Tax Provision: 11585000.00
CNS income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.24
CNS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.27
CNS balance_sheet (annual, 2025-12-31) — Total Assets: 876694000.00
CNS balance_sheet (quarterly, 2025-12-31) — Total Assets: 876694000.00
CNS balance_sheet (annual, 2025-12-31) — Total Capitalization: 561953000.00
CNS balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 561953000.00
CNS balance_sheet (annual, 2025-12-31) — Total Debt: 138326000.00
CNS balance_sheet (quarterly, 2025-12-31) — Total Debt: 138326000.00
CNS balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 633848000.00
CNS balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 633848000.00
CNS income_statement (annual, 2025-12-31) — Total Expenses: 378380000.00
CNS income_statement (quarterly, 2025-12-31) — Total Expenses: 103493000.00
CNS balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 242846000.00
CNS balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 242846000.00
CNS balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 484159000.00
CNS balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 484159000.00
CNS balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 232254000.00
CNS balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 232254000.00
CNS income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 177736000.00
CNS income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 40310000.00
CNS balance_sheet (annual, 2025-12-31) — Total Tax Payable: 1650000.00
CNS balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 1650000.00
CNS income_statement (annual, 2025-12-31) — Total Unusual Items: 4885000.00
CNS income_statement (quarterly, 2025-12-31) — Total Unusual Items: -3239000.00
CNS income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 4885000.00
CNS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -3239000.00
CNS balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 7243851.00
CNS balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 7243851.00
CNS balance_sheet (annual, 2025-12-31) — Treasury Stock: 321115000.00
CNS balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 321115000.00
CNS balance_sheet (annual, 2025-12-31) — Working Capital: 381943000.00
CNS balance_sheet (quarterly, 2025-12-31) — Working Capital: 381943000.00
CNS income_statement (quarterly, 2026-03-31) — +Operating Expense: 21478000.00
CNS income_statement (quarterly, 2026-03-31) — +Total Revenue: 150946000.00
CNS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 7891000.00
CNS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 88602000.00
CNS balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 1004985000.00
CNS cash_flow (quarterly, 2026-03-31) — Amortization Of Securities: 361000.00
CNS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 307808000.00
CNS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 51441000.00
CNS income_statement (quarterly, 2026-03-31) — Basic EPS: 0.82
CNS cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 146604000.00
CNS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 136323000.00
CNS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 589000.00
CNS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 53094000.00
CNS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 252951000.00
CNS cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -34524000.00
CNS cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -13651000.00
CNS cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -24813000.00
CNS cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -51364000.00
CNS cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -60164000.00
CNS cash_flow (quarterly, 2026-03-31) — Change In Dividend Payable: -732000.00
CNS cash_flow (quarterly, 2026-03-31) — Change In Income Tax Payable: 6400000.00
CNS cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: -46179000.00
CNS cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -4842000.00
CNS cash_flow (quarterly, 2026-03-31) — Change In Payable: 5630000.00
CNS cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -54534000.00
CNS cash_flow (quarterly, 2026-03-31) — Change In Receivables: -9412000.00
CNS cash_flow (quarterly, 2026-03-31) — Change In Tax Payable: 6400000.00
CNS cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -114967000.00
CNS cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -9038000.00
CNS cash_flow (quarterly, 2026-03-31) — Changes In Cash: -89828000.00
CNS balance_sheet (quarterly, 2026-03-31) — Common Stock: 589000.00
CNS cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -34524000.00
CNS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 563351000.00
CNS cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -16917000.00
CNS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 74039000.00
CNS balance_sheet (quarterly, 2026-03-31) — Current Assets: 344120000.00
CNS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 14371000.00
CNS cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 7859000.00
CNS cash_flow (quarterly, 2026-03-31) — Deferred Tax: 7859000.00
CNS cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 3130000.00
CNS income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 2574000.00
CNS cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 3130000.00
CNS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 2574000.00
CNS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 51595000.00
CNS income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.82
CNS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 42368000.00
CNS income_statement (quarterly, 2026-03-31) — EBIT: 55429000.00
CNS income_statement (quarterly, 2026-03-31) — EBITDA: 58559000.00
CNS cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -460000.00
CNS balance_sheet (quarterly, 2026-03-31) — Employee Benefits: 20450000.00
CNS cash_flow (quarterly, 2026-03-31) — End Cash Position: 56316000.00
CNS cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -13651000.00
CNS cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -51364000.00
CNS cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: -1011000.00
CNS income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 1770000.00
CNS balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -5380000.00
CNS income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 18904000.00
CNS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 19835000.00
CNS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 158152000.00
CNS income_statement (quarterly, 2026-03-31) — Gross Profit: 76907000.00
CNS balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 5674000.00
CNS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 563351000.00
CNS cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -24813000.00
CNS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 307808000.00
CNS balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 307817000.00
CNS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 136323000.00
CNS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 136323000.00
CNS balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 9000.00
CNS balance_sheet (quarterly, 2026-03-31) — Minority Interest: 103619000.00
CNS income_statement (quarterly, 2026-03-31) — Minority Interests: 1148000.00
CNS cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -16917000.00
CNS cash_flow (quarterly, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: -84000.00
CNS income_statement (quarterly, 2026-03-31) — Net Income: 42368000.00
CNS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 42368000.00
CNS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 41220000.00
CNS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 42368000.00
CNS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 42368000.00
CNS cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 41220000.00
CNS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 41220000.00
CNS cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -24921000.00
CNS cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: 37389000.00
CNS balance_sheet (quarterly, 2026-03-31) — Net PPE: 158152000.00
CNS cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: 108000.00
CNS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 543516000.00
CNS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 56789000.00
CNS income_statement (quarterly, 2026-03-31) — Normalized Income: 41092463.71
CNS cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -51364000.00
CNS cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -1095000.00
CNS income_statement (quarterly, 2026-03-31) — Operating Income: 55429000.00
CNS income_statement (quarterly, 2026-03-31) — Operating Revenue: 150188000.00
CNS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 51402576.00
CNS balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -5380000.00
CNS income_statement (quarterly, 2026-03-31) — Other Gand A: 18904000.00
CNS income_statement (quarterly, 2026-03-31) — Other Income Expense: 1770000.00
CNS cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 1335000.00
CNS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 24805000.00
CNS balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 16615000.00
CNS balance_sheet (quarterly, 2026-03-31) — Other Payable: 806000.00
CNS balance_sheet (quarterly, 2026-03-31) — Other Properties: 158152000.00
CNS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 2567000.00
CNS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 199857000.00
CNS balance_sheet (quarterly, 2026-03-31) — Payables: 14371000.00
CNS balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 14371000.00
CNS income_statement (quarterly, 2026-03-31) — Pretax Income: 57199000.00
CNS cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 401000.00
CNS cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -141392000.00
CNS balance_sheet (quarterly, 2026-03-31) — Receivables: 91169000.00
CNS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 73483000.00
CNS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 3130000.00
CNS cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -16917000.00
CNS balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -98910000.00
CNS cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 116471000.00
CNS cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 108000.00
CNS income_statement (quarterly, 2026-03-31) — Selling General And Administration: 18904000.00
CNS balance_sheet (quarterly, 2026-03-31) — Share Issued: 58906042.00
CNS cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 10793000.00
CNS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 563351000.00
CNS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 543516000.00
CNS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 494463.71
CNS income_statement (quarterly, 2026-03-31) — Tax Provision: 15979000.00
CNS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.28
CNS balance_sheet (quarterly, 2026-03-31) — Total Assets: 854729000.00
CNS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 563351000.00
CNS balance_sheet (quarterly, 2026-03-31) — Total Debt: 136323000.00
CNS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 666970000.00
CNS income_statement (quarterly, 2026-03-31) — Total Expenses: 95517000.00
CNS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 187759000.00
CNS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 510609000.00
CNS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 173388000.00
CNS income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 50122000.00
CNS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 5674000.00
CNS income_statement (quarterly, 2026-03-31) — Total Unusual Items: 1770000.00
CNS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 1770000.00
CNS balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 7503466.00
CNS balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 337933000.00
CNS balance_sheet (quarterly, 2026-03-31) — Working Capital: 329749000.00
CNS income_statement (quarterly, 2026-06-30) — Basic Average Shares: 51545000.00
CNS income_statement (quarterly, 2026-06-30) — Basic EPS: 0.96
CNS income_statement (quarterly, 2026-06-30) — Diluted Average Shares: 51861000.00
CNS income_statement (quarterly, 2026-06-30) — Diluted EPS: 0.95
CNS.L balance_sheet (annual, 2021-12-31) — Current Debt: 1421000.00
CNS.L cash_flow (annual, 2021-12-31) — Issuance Of Debt: 2683000.00
CNS.L balance_sheet (annual, 2021-12-31) — Long Term Debt: 1356000.00
CNS.L cash_flow (annual, 2021-12-31) — Long Term Debt Issuance: 2683000.00
CNS.L cash_flow (annual, 2021-12-31) — Long Term Debt Payments: -1738000.00
CNS.L cash_flow (annual, 2021-12-31) — Net Intangibles Purchase And Sale: -1754000.00
CNS.L cash_flow (annual, 2021-12-31) — Net Issuance Payments Of Debt: 945000.00
CNS.L cash_flow (annual, 2021-12-31) — Net Long Term Debt Issuance: 945000.00
CNS.L cash_flow (annual, 2021-12-31) — Net Other Financing Charges: 1000.00
CNS.L income_statement (annual, 2021-12-31) — Other Special Charges: -637000.00
CNS.L cash_flow (annual, 2021-12-31) — Purchase Of Intangibles: -1754000.00
CNS.L cash_flow (annual, 2021-12-31) — Repayment Of Debt: -1738000.00
CNS.L income_statement (annual, 2021-12-31) — Special Income Charges: 637000.00
CNS.L income_statement (annual, 2021-12-31) — Total Unusual Items: 637000.00
CNS.L income_statement (annual, 2021-12-31) — Total Unusual Items Excluding Goodwill: 637000.00
CNS.L balance_sheet (annual, 2021-12-31) — Tradeand Other Payables Non Current: 143000.00
CNS.L income_statement (annual, 2022-12-31) — +Operating Expense: 16869000.00
CNS.L income_statement (annual, 2022-12-31) — +Total Revenue: 20121000.00
CNS.L balance_sheet (annual, 2022-12-31) — Accounts Payable: 3956000.00
CNS.L balance_sheet (annual, 2022-12-31) — Accounts Receivable: 1067000.00
CNS.L balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -2911000.00
CNS.L balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 89335000.00
CNS.L balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -25000.00
CNS.L cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 1734000.00
CNS.L income_statement (annual, 2022-12-31) — Basic Average Shares: 554000000.00
CNS.L income_statement (annual, 2022-12-31) — Basic EPS: 0.00
CNS.L cash_flow (annual, 2022-12-31) — Beginning Cash Position: 11201000.00
CNS.L balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 104000.00
CNS.L cash_flow (annual, 2022-12-31) — Capital Expenditure: -2124000.00
CNS.L cash_flow (annual, 2022-12-31) — Capital Expenditure Reported: -1704000.00
CNS.L balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 78000.00
CNS.L balance_sheet (annual, 2022-12-31) — Capital Stock: 6980000.00
CNS.L balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 5646000.00
CNS.L balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 5646000.00
CNS.L cash_flow (annual, 2022-12-31) — Change In Inventory: -26000.00
CNS.L cash_flow (annual, 2022-12-31) — Change In Payable: -1361000.00
CNS.L cash_flow (annual, 2022-12-31) — Change In Receivables: -3867000.00
CNS.L cash_flow (annual, 2022-12-31) — Change In Working Capital: -5254000.00
CNS.L cash_flow (annual, 2022-12-31) — Changes In Cash: -5244000.00
CNS.L balance_sheet (annual, 2022-12-31) — Common Stock: 6980000.00
CNS.L balance_sheet (annual, 2022-12-31) — Common Stock Equity: 15884000.00
CNS.L cash_flow (annual, 2022-12-31) — Common Stock Issuance: 228000.00
CNS.L income_statement (annual, 2022-12-31) — Cost Of Revenue: 2576000.00
CNS.L balance_sheet (annual, 2022-12-31) — Current Assets: 12675000.00
CNS.L balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 78000.00
CNS.L balance_sheet (annual, 2022-12-31) — Current Debt: 971000.00
CNS.L balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 1049000.00
CNS.L balance_sheet (annual, 2022-12-31) — Current Deferred Assets: 1110000.00
CNS.L balance_sheet (annual, 2022-12-31) — Current Liabilities: 8328000.00
CNS.L cash_flow (annual, 2022-12-31) — Depreciation: 579000.00
CNS.L cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 2313000.00
CNS.L income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 1943000.00
CNS.L income_statement (annual, 2022-12-31) — Depreciation Income Statement: 1943000.00
CNS.L income_statement (annual, 2022-12-31) — Diluted Average Shares: 554000000.00
CNS.L income_statement (annual, 2022-12-31) — Diluted EPS: 0.00
CNS.L income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 554000.00
CNS.L income_statement (annual, 2022-12-31) — EBIT: 683000.00
CNS.L income_statement (annual, 2022-12-31) — EBITDA: 2996000.00
CNS.L cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -311000.00
CNS.L cash_flow (annual, 2022-12-31) — End Cash Position: 5646000.00
CNS.L cash_flow (annual, 2022-12-31) — Financing Cash Flow: -1398000.00
CNS.L cash_flow (annual, 2022-12-31) — Free Cash Flow: -3853000.00
CNS.L balance_sheet (annual, 2022-12-31) — Goodwill: 8991000.00
CNS.L balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 13493000.00
CNS.L balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 1092000.00
CNS.L balance_sheet (annual, 2022-12-31) — Gross PPE: 3577000.00
CNS.L income_statement (annual, 2022-12-31) — Gross Profit: 17545000.00
CNS.L income_statement (annual, 2022-12-31) — Interest Expense: 279000.00
CNS.L income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 279000.00
CNS.L income_statement (annual, 2022-12-31) — Interest Income: 7000.00
CNS.L income_statement (annual, 2022-12-31) — Interest Income Non Operating: 7000.00
CNS.L cash_flow (annual, 2022-12-31) — Interest Paid Cff: -158000.00
CNS.L cash_flow (annual, 2022-12-31) — Interest Received Cfi: 7000.00
CNS.L balance_sheet (annual, 2022-12-31) — Inventories Adjustments Allowances: -53000.00
CNS.L balance_sheet (annual, 2022-12-31) — Inventory: 164000.00
CNS.L balance_sheet (annual, 2022-12-31) — Invested Capital: 17092000.00
CNS.L cash_flow (annual, 2022-12-31) — Investing Cash Flow: -2117000.00
CNS.L cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 228000.00
CNS.L cash_flow (annual, 2022-12-31) — Issuance Of Debt: 0.00
CNS.L balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 0.00
CNS.L balance_sheet (annual, 2022-12-31) — Long Term Debt: 237000.00
CNS.L balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 237000.00
CNS.L cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 0.00
CNS.L cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -1364000.00
CNS.L balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 1194000.00
CNS.L cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 228000.00
CNS.L income_statement (annual, 2022-12-31) — Net Income: 554000.00
CNS.L income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 554000.00
CNS.L income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 554000.00
CNS.L income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 554000.00
CNS.L income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 554000.00
CNS.L cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 404000.00
CNS.L income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 554000.00
CNS.L cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -1704000.00
CNS.L income_statement (annual, 2022-12-31) — Net Interest Income: -272000.00
CNS.L cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -1364000.00
CNS.L cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -1364000.00
CNS.L income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -272000.00
CNS.L cash_flow (annual, 2022-12-31) — Net Other Financing Charges: 7000.00
CNS.L balance_sheet (annual, 2022-12-31) — Net PPE: 666000.00
CNS.L cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -420000.00
CNS.L balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 2391000.00
CNS.L balance_sheet (annual, 2022-12-31) — Non Current Deferred Revenue: 2285000.00
CNS.L income_statement (annual, 2022-12-31) — Normalized EBITDA: 2996000.00
CNS.L income_statement (annual, 2022-12-31) — Normalized Income: 554000.00
CNS.L cash_flow (annual, 2022-12-31) — Operating Cash Flow: -1729000.00
CNS.L income_statement (annual, 2022-12-31) — Operating Income: 676000.00
CNS.L income_statement (annual, 2022-12-31) — Operating Revenue: 20121000.00
CNS.L balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 499953971.00
CNS.L balance_sheet (annual, 2022-12-31) — Other Equity Interest: 1777000.00
CNS.L balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 4502000.00
CNS.L balance_sheet (annual, 2022-12-31) — Other Inventories: 217000.00
CNS.L cash_flow (annual, 2022-12-31) — Other Non Cash Items: 272000.00
CNS.L income_statement (annual, 2022-12-31) — Other Operating Expenses: 14926000.00
CNS.L balance_sheet (annual, 2022-12-31) — Other Properties: 2279000.00
CNS.L balance_sheet (annual, 2022-12-31) — Other Receivables: 2953000.00
CNS.L income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 0.00
CNS.L balance_sheet (annual, 2022-12-31) — Payables: 3956000.00
CNS.L balance_sheet (annual, 2022-12-31) — Prepaid Assets: 1735000.00
CNS.L income_statement (annual, 2022-12-31) — Pretax Income: 404000.00
CNS.L balance_sheet (annual, 2022-12-31) — Properties: 0.00
CNS.L cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: -1704000.00
CNS.L cash_flow (annual, 2022-12-31) — Purchase Of PPE: -420000.00
CNS.L income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 2576000.00
CNS.L income_statement (annual, 2022-12-31) — Reconciled Depreciation: 2313000.00
CNS.L cash_flow (annual, 2022-12-31) — Repayment Of Debt: -1364000.00
CNS.L balance_sheet (annual, 2022-12-31) — Retained Earnings: -79615000.00
CNS.L balance_sheet (annual, 2022-12-31) — Share Issued: 499953971.00
CNS.L income_statement (annual, 2022-12-31) — Special Income Charges: 0.00
CNS.L cash_flow (annual, 2022-12-31) — Stock Based Compensation: 386000.00
CNS.L balance_sheet (annual, 2022-12-31) — Stockholders Equity: 15884000.00
CNS.L balance_sheet (annual, 2022-12-31) — Tangible Book Value: 2391000.00
CNS.L income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
CNS.L income_statement (annual, 2022-12-31) — Tax Provision: -150000.00
CNS.L income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.19
CNS.L cash_flow (annual, 2022-12-31) — Taxes Refund Paid: 150000.00
CNS.L balance_sheet (annual, 2022-12-31) — Total Assets: 26834000.00
CNS.L balance_sheet (annual, 2022-12-31) — Total Capitalization: 16121000.00
CNS.L balance_sheet (annual, 2022-12-31) — Total Debt: 1286000.00
CNS.L balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 15884000.00
CNS.L income_statement (annual, 2022-12-31) — Total Expenses: 19445000.00
CNS.L balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 10950000.00
CNS.L balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 14159000.00
CNS.L balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 2622000.00
CNS.L income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 676000.00
CNS.L income_statement (annual, 2022-12-31) — Total Unusual Items: 0.00
CNS.L income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 0.00
CNS.L balance_sheet (annual, 2022-12-31) — Tradeand Other Payables Non Current: 100000.00
CNS.L balance_sheet (annual, 2022-12-31) — Working Capital: 4347000.00
CNS.L income_statement (annual, 2023-12-31) — +Operating Expense: 20201000.00
CNS.L income_statement (annual, 2023-12-31) — +Total Revenue: 22349000.00
CNS.L balance_sheet (annual, 2023-12-31) — Accounts Payable: 1399000.00
CNS.L balance_sheet (annual, 2023-12-31) — Accounts Receivable: 2281000.00
CNS.L balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -3007000.00
CNS.L balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 89481000.00
CNS.L balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -25000.00
CNS.L cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 1506000.00
CNS.L income_statement (annual, 2023-12-31) — Basic Average Shares: 501528468.00
CNS.L income_statement (annual, 2023-12-31) — Basic EPS: 0.00
CNS.L cash_flow (annual, 2023-12-31) — Beginning Cash Position: 5646000.00
CNS.L balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 105000.00
CNS.L cash_flow (annual, 2023-12-31) — Capital Expenditure: -2636000.00
CNS.L cash_flow (annual, 2023-12-31) — Capital Expenditure Reported: -1824000.00
CNS.L balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 315000.00
CNS.L balance_sheet (annual, 2023-12-31) — Capital Stock: 6999000.00
CNS.L balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 5160000.00
CNS.L balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 5160000.00
CNS.L balance_sheet (annual, 2023-12-31) — Cash Financial: 5160000.00
CNS.L cash_flow (annual, 2023-12-31) — Change In Inventory: 68000.00
CNS.L cash_flow (annual, 2023-12-31) — Change In Payable: 2035000.00
CNS.L cash_flow (annual, 2023-12-31) — Change In Receivables: -1248000.00
CNS.L cash_flow (annual, 2023-12-31) — Change In Working Capital: 855000.00
CNS.L cash_flow (annual, 2023-12-31) — Changes In Cash: -835000.00
CNS.L balance_sheet (annual, 2023-12-31) — Common Stock: 6999000.00
CNS.L balance_sheet (annual, 2023-12-31) — Common Stock Equity: 16737000.00
CNS.L cash_flow (annual, 2023-12-31) — Common Stock Issuance: 165000.00
CNS.L income_statement (annual, 2023-12-31) — Cost Of Revenue: 2164000.00
CNS.L balance_sheet (annual, 2023-12-31) — Current Assets: 13683000.00
CNS.L balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 164000.00
CNS.L balance_sheet (annual, 2023-12-31) — Current Debt: 0.00
CNS.L balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 164000.00
CNS.L balance_sheet (annual, 2023-12-31) — Current Deferred Assets: 1357000.00
CNS.L balance_sheet (annual, 2023-12-31) — Current Liabilities: 9058000.00
CNS.L cash_flow (annual, 2023-12-31) — Depreciation: 539000.00
CNS.L cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 2045000.00
CNS.L income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 1773000.00
CNS.L income_statement (annual, 2023-12-31) — Depreciation Income Statement: 1773000.00
CNS.L income_statement (annual, 2023-12-31) — Diluted Average Shares: 501528468.00
CNS.L income_statement (annual, 2023-12-31) — Diluted EPS: 0.00
CNS.L income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -170000.00
CNS.L income_statement (annual, 2023-12-31) — EBIT: 28000.00
CNS.L income_statement (annual, 2023-12-31) — EBITDA: 2073000.00
CNS.L cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 349000.00
CNS.L cash_flow (annual, 2023-12-31) — End Cash Position: 5160000.00
CNS.L cash_flow (annual, 2023-12-31) — Financing Cash Flow: -1373000.00
CNS.L cash_flow (annual, 2023-12-31) — Free Cash Flow: 494000.00
CNS.L balance_sheet (annual, 2023-12-31) — Goodwill: 8991000.00
CNS.L balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 13811000.00
CNS.L balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 2306000.00
CNS.L balance_sheet (annual, 2023-12-31) — Gross PPE: 3949000.00
CNS.L income_statement (annual, 2023-12-31) — Gross Profit: 20185000.00
CNS.L income_statement (annual, 2023-12-31) — Interest Expense: 181000.00
CNS.L income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 181000.00
CNS.L income_statement (annual, 2023-12-31) — Interest Income: 44000.00
CNS.L income_statement (annual, 2023-12-31) — Interest Income Non Operating: 44000.00
CNS.L cash_flow (annual, 2023-12-31) — Interest Paid Cff: -78000.00
CNS.L cash_flow (annual, 2023-12-31) — Interest Received Cfi: 44000.00
CNS.L balance_sheet (annual, 2023-12-31) — Inventories Adjustments Allowances: -64000.00
CNS.L balance_sheet (annual, 2023-12-31) — Inventory: 96000.00
CNS.L balance_sheet (annual, 2023-12-31) — Invested Capital: 16737000.00
CNS.L cash_flow (annual, 2023-12-31) — Investing Cash Flow: -2592000.00
CNS.L cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 165000.00
CNS.L balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 151000.00
CNS.L balance_sheet (annual, 2023-12-31) — Long Term Debt: 0.00
CNS.L balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 151000.00
CNS.L cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -1317000.00
CNS.L balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 930000.00
CNS.L cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 165000.00
CNS.L income_statement (annual, 2023-12-31) — Net Income: -170000.00
CNS.L income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -170000.00
CNS.L income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -170000.00
CNS.L income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -170000.00
CNS.L income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -170000.00
CNS.L cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -153000.00
CNS.L income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -170000.00
CNS.L income_statement (annual, 2023-12-31) — Net Interest Income: -137000.00
CNS.L cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -1317000.00
CNS.L cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -1317000.00
CNS.L income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -137000.00
CNS.L balance_sheet (annual, 2023-12-31) — Net PPE: 942000.00
CNS.L cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -812000.00
CNS.L balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 2926000.00
CNS.L balance_sheet (annual, 2023-12-31) — Non Current Deferred Revenue: 2491000.00
CNS.L income_statement (annual, 2023-12-31) — Normalized EBITDA: 2073000.00
CNS.L income_statement (annual, 2023-12-31) — Normalized Income: -170000.00
CNS.L cash_flow (annual, 2023-12-31) — Operating Cash Flow: 3130000.00
CNS.L income_statement (annual, 2023-12-31) — Operating Income: -16000.00
CNS.L income_statement (annual, 2023-12-31) — Operating Revenue: 22349000.00
CNS.L balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 501528468.00
CNS.L balance_sheet (annual, 2023-12-31) — Other Equity Interest: 2007000.00
CNS.L balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 4820000.00
CNS.L balance_sheet (annual, 2023-12-31) — Other Inventories: 160000.00
CNS.L cash_flow (annual, 2023-12-31) — Other Non Cash Items: 167000.00
CNS.L balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: -1000.00
CNS.L income_statement (annual, 2023-12-31) — Other Operating Expenses: 18428000.00
CNS.L balance_sheet (annual, 2023-12-31) — Other Payable: 619000.00
CNS.L balance_sheet (annual, 2023-12-31) — Other Properties: 2914000.00
CNS.L balance_sheet (annual, 2023-12-31) — Other Receivables: 2962000.00
CNS.L income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 0.00
CNS.L balance_sheet (annual, 2023-12-31) — Payables: 2018000.00
CNS.L balance_sheet (annual, 2023-12-31) — Prepaid Assets: 1827000.00
CNS.L income_statement (annual, 2023-12-31) — Pretax Income: -153000.00
CNS.L balance_sheet (annual, 2023-12-31) — Properties: 0.00
CNS.L cash_flow (annual, 2023-12-31) — Purchase Of PPE: -812000.00
CNS.L income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 2164000.00
CNS.L income_statement (annual, 2023-12-31) — Reconciled Depreciation: 2045000.00
CNS.L cash_flow (annual, 2023-12-31) — Repayment Of Debt: -1317000.00
CNS.L balance_sheet (annual, 2023-12-31) — Retained Earnings: -79785000.00
CNS.L balance_sheet (annual, 2023-12-31) — Share Issued: 501528468.00
CNS.L cash_flow (annual, 2023-12-31) — Stock Based Compensation: 233000.00
CNS.L balance_sheet (annual, 2023-12-31) — Stockholders Equity: 16737000.00
CNS.L balance_sheet (annual, 2023-12-31) — Tangible Book Value: 2926000.00
CNS.L income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
CNS.L income_statement (annual, 2023-12-31) — Tax Provision: 17000.00
CNS.L income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.19
CNS.L cash_flow (annual, 2023-12-31) — Taxes Refund Paid: -17000.00
CNS.L balance_sheet (annual, 2023-12-31) — Total Assets: 28436000.00
CNS.L balance_sheet (annual, 2023-12-31) — Total Capitalization: 16737000.00
CNS.L balance_sheet (annual, 2023-12-31) — Total Debt: 315000.00
CNS.L balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 16737000.00
CNS.L income_statement (annual, 2023-12-31) — Total Expenses: 22365000.00
CNS.L balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 11699000.00
CNS.L balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 14753000.00
CNS.L balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 2641000.00
CNS.L income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -16000.00
CNS.L balance_sheet (annual, 2023-12-31) — Working Capital: 4625000.00
CNS.L income_statement (annual, 2024-12-31) — +Operating Expense: 21933000.00
CNS.L income_statement (annual, 2024-12-31) — +Total Revenue: 24559000.00
CNS.L balance_sheet (annual, 2024-12-31) — Accounts Payable: 1574000.00
CNS.L balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 1574000.00
CNS.L balance_sheet (annual, 2024-12-31) — Accounts Receivable: 4093000.00
CNS.L balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 4093000.00
CNS.L balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -2969000.00
CNS.L balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -2969000.00
CNS.L balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 90341000.00
CNS.L balance_sheet (quarterly, 2024-12-31) — Additional Paid In Capital: 90341000.00
CNS.L balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -314000.00
CNS.L balance_sheet (quarterly, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -314000.00
CNS.L cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 1588000.00
CNS.L income_statement (annual, 2024-12-31) — Basic Average Shares: 498000000.00
CNS.L income_statement (annual, 2024-12-31) — Basic EPS: 0.00
CNS.L cash_flow (annual, 2024-12-31) — Beginning Cash Position: 5160000.00
CNS.L balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 105000.00
CNS.L balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 105000.00
CNS.L cash_flow (annual, 2024-12-31) — Capital Expenditure: -3979000.00
CNS.L cash_flow (annual, 2024-12-31) — Capital Expenditure Reported: -3190000.00
CNS.L balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 150000.00
CNS.L balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 150000.00
CNS.L balance_sheet (annual, 2024-12-31) — Capital Stock: 7133000.00
CNS.L balance_sheet (quarterly, 2024-12-31) — Capital Stock: 7133000.00
CNS.L balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 5321000.00
CNS.L balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 5321000.00
CNS.L balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 5321000.00
CNS.L balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 5321000.00
CNS.L balance_sheet (annual, 2024-12-31) — Cash Financial: 5321000.00
CNS.L balance_sheet (quarterly, 2024-12-31) — Cash Financial: 5321000.00
CNS.L cash_flow (annual, 2024-12-31) — Change In Inventory: -293000.00
CNS.L cash_flow (annual, 2024-12-31) — Change In Payable: 3297000.00
CNS.L cash_flow (annual, 2024-12-31) — Change In Receivables: -2863000.00
CNS.L cash_flow (annual, 2024-12-31) — Change In Working Capital: 141000.00
CNS.L cash_flow (annual, 2024-12-31) — Changes In Cash: 172000.00
CNS.L balance_sheet (annual, 2024-12-31) — Common Stock: 7133000.00
CNS.L balance_sheet (quarterly, 2024-12-31) — Common Stock: 7133000.00
CNS.L balance_sheet (annual, 2024-12-31) — Common Stock Equity: 18664000.00
CNS.L balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: 18664000.00
CNS.L cash_flow (annual, 2024-12-31) — Common Stock Issuance: 994000.00
CNS.L income_statement (annual, 2024-12-31) — Cost Of Revenue: 2134000.00
CNS.L balance_sheet (annual, 2024-12-31) — Current Assets: 17000000.00
CNS.L balance_sheet (quarterly, 2024-12-31) — Current Assets: 17000000.00
CNS.L balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 102000.00
CNS.L balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 102000.00
CNS.L balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 102000.00
CNS.L balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 102000.00
CNS.L balance_sheet (annual, 2024-12-31) — Current Deferred Assets: 1605000.00
CNS.L balance_sheet (quarterly, 2024-12-31) — Current Deferred Assets: 1605000.00
CNS.L balance_sheet (annual, 2024-12-31) — Current Liabilities: 11303000.00
CNS.L balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 11303000.00
CNS.L cash_flow (annual, 2024-12-31) — Depreciation: 637000.00
CNS.L cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 2225000.00
CNS.L income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 2008000.00
CNS.L income_statement (annual, 2024-12-31) — Depreciation Income Statement: 2008000.00
CNS.L income_statement (annual, 2024-12-31) — Diluted Average Shares: 498000000.00
CNS.L income_statement (annual, 2024-12-31) — Diluted EPS: 0.00
CNS.L income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 498000.00
CNS.L income_statement (annual, 2024-12-31) — EBIT: 591000.00
CNS.L income_statement (annual, 2024-12-31) — EBITDA: 2816000.00
CNS.L cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -10000.00
CNS.L cash_flow (annual, 2024-12-31) — End Cash Position: 5321000.00
CNS.L cash_flow (annual, 2024-12-31) — Financing Cash Flow: 765000.00
CNS.L cash_flow (annual, 2024-12-31) — Free Cash Flow: -693000.00
CNS.L balance_sheet (annual, 2024-12-31) — Goodwill: 8991000.00
CNS.L balance_sheet (quarterly, 2024-12-31) — Goodwill: 8991000.00
CNS.L balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 15413000.00
CNS.L balance_sheet (quarterly, 2024-12-31) — Goodwill And Other Intangible Assets: 15413000.00
CNS.L balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 4407000.00
CNS.L balance_sheet (quarterly, 2024-12-31) — Gross Accounts Receivable: 4407000.00
CNS.L balance_sheet (annual, 2024-12-31) — Gross PPE: 4052000.00
CNS.L balance_sheet (quarterly, 2024-12-31) — Gross PPE: 4052000.00
CNS.L income_statement (annual, 2024-12-31) — Gross Profit: 22425000.00
CNS.L income_statement (annual, 2024-12-31) — Interest Expense: 36000.00
CNS.L income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 36000.00
CNS.L income_statement (annual, 2024-12-31) — Interest Income: 99000.00
CNS.L income_statement (annual, 2024-12-31) — Interest Income Non Operating: 99000.00
CNS.L cash_flow (annual, 2024-12-31) — Interest Paid Cff: -36000.00
CNS.L cash_flow (annual, 2024-12-31) — Interest Received Cfi: 99000.00
CNS.L balance_sheet (annual, 2024-12-31) — Inventories Adjustments Allowances: -65000.00
CNS.L balance_sheet (quarterly, 2024-12-31) — Inventories Adjustments Allowances: -65000.00
CNS.L balance_sheet (annual, 2024-12-31) — Inventory: 389000.00
CNS.L balance_sheet (quarterly, 2024-12-31) — Inventory: 389000.00
CNS.L balance_sheet (annual, 2024-12-31) — Invested Capital: 18664000.00
CNS.L balance_sheet (quarterly, 2024-12-31) — Invested Capital: 18664000.00
CNS.L cash_flow (annual, 2024-12-31) — Investing Cash Flow: -3879000.00
CNS.L cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 994000.00
CNS.L balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 48000.00
CNS.L balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 48000.00